Concord Biotech shares gain 6% after USFDA approval for Tofacitinib tabletsConcord Biotech's shares surged over 6% after receiving USFDA approval for its Tofacitinib Tablets in 5 mg and 10 mg strengths. This approv...
10 Jun, 2026, 01.11 PM IST
India willing to open its market to high-quality, innovative pharma products, says commerce ministerIndia is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...
08 Jun, 2026, 09.55 PM IST
Concord Biotech shares jump 8% on USFDA nod for Mycophenolate Mofetil oral suspensionConcord Biotech shares saw a significant jump on Wednesday. This surge followed the company's announcement of receiving approval from the U...
03 Jun, 2026, 11.39 AM IST
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
02 Jun, 2026, 05.48 AM IST
India-Oman CEPA kicks in June 1: What gets cheaper, which sectors gain, and key benefits explainedIndia's Comprehensive Economic Partnership Agreement with Oman comes into effect on June 1, granting New Delhi 100% duty-free access for 98...
01 Jun, 2026, 12.24 AM IST
Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...
30 May, 2026, 11.17 PM IST
Alembic gets USFDA nod for generic levothyroxine sodium tabletsAlembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medicati...
22 May, 2026, 12.23 PM IST
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...
14 May, 2026, 04.32 PM IST
Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27Dr Reddy's Laboratories anticipates a gradual recovery this fiscal year. The company faced a profit drop last year due to US business press...
14 May, 2026, 06.14 AM IST
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
05 May, 2026, 05.35 PM IST
Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...
23 Apr, 2026, 01.38 PM IST
Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...
16 Apr, 2026, 01.06 PM IST
Advent International to acquire stake in Felix PharmaceuticalsAdvent International is set to invest $175 million in Felix Pharmaceuticals, acquiring a significant minority stake. Felix Pharma, a Dublin...
09 Jun, 2025, 11.10 AM IST
USFDA denies approval for SPARC's anti-glaucoma eyedropSun Pharma Advanced Research Company (SPARC) today said the US health regulator has not approved its new drug application for anti-glaucoma...
01 Aug, 2015, 12.42 PM IST
- Sharekhan puts buy on Lupin
Sharekhan has come out with a ‘buy’ on Lupin on account of its differentiated business model with global dominance in certain products, foc...
24 Dec, 2008, 02.00 AM IST
- Glenmark gets tentative FDA nod for Topiramte
Glenmark Pharmaceuticals says it has received the USFDA tentative approval to market Topiramate tablets.
02 Jul, 2007, 04.20 PM IST
- Wockhardt gets nod for new drug
Wockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
14 Jun, 2006, 02.40 PM IST